Moderna, Inc. (MRNA)
47.75
+0.15
(+0.32%)
USD |
NASDAQ |
Jun 09, 16:00
47.55
-0.20
(-0.42%)
After-Hours: 19:50
Moderna SG&A Expense (Quarterly) : 173.00M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| BioNTech SE | 176.43M |
| Sarepta Therapeutics, Inc. | 108.95M |
| Erasca, Inc. | 10.65M |
| Replimune Group, Inc. | 18.73M |
| Revolution Medicines, Inc. | 101.25M |